BiotechTube

REOLYSIN®

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Osteosarcoma

Conditions

Osteosarcoma, Ewing Sarcoma Family Tumors, Malignant Fibrous Histiocytoma, Sarcoma, Synovial, Fibrosarcoma, Leiomyosarcoma

Trial Timeline

Jun 1, 2007 → Apr 1, 2011

NCT ID
NCT00503295

About REOLYSIN®

REOLYSIN® is a phase 2 stage product being developed by Oncolytics Biotech for Osteosarcoma. The current trial status is completed. This product is registered under clinical trial identifier NCT00503295. Target conditions include Osteosarcoma, Ewing Sarcoma Family Tumors, Malignant Fibrous Histiocytoma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT00503295Phase 2Completed
NCT00528684Phase 1Completed

Competing Products

18 competing products in Osteosarcoma

See all competitors
ProductCompanyStageHype Score
Azenosertib + GemcitabineZentalis PharmaceuticalsPhase 1/2
33
Lenvatinib + Ifosfamide + Etoposide + LenvatinibEisaiPhase 2
52
PemetrexedEli LillyPhase 2
52
pemetrexedEli LillyPhase 2
52
Camrelizumab in Combination With Neoadjuvant ChemotherapyJiangsu Hengrui MedicinePhase 2
52
ApatinibJiangsu Hengrui MedicinePhase 2
52
Olaparib + CeralasertibAstraZenecaPhase 2
52
Saracatinib + PlaceboAstraZenecaPhase 2
52
robatumumabMerckPhase 2
52
PembrolizumabMerckPhase 2
52
pazopanibNovartisPhase 2
52
AvelumabPfizerPhase 2
51
Nivolumab + AzacitidineBristol Myers SquibbPhase 1
32
Nivolumab + IpilimumabBristol Myers SquibbPhase 2
51
Cisplatin liposomalInsmedPhase 1/2
38
CabozantinibIpsenPhase 2
49
Sm-EDTMPJazz PharmaceuticalsPhase 2
49
LNTH2403 Phase 1 dose + Phase 2; LNTH2403 a single agent recommended phase 2 dose (RP2D).Lantheus HoldingsPhase 1/2
38

Other Products from Oncolytics Biotech

REOLYSIN + Carboplatin + Paclitaxel + PlaceboPhase 3
69
Bevacizumab + FOLFIRI + PelareorepPhase 2
44
Pemetrexed and Reolysin (and safety run-in) + Pemetrexed + Docetaxel and Reolysin + DocetaxelPhase 2
44
REOLYSIN + Carboplatin + PaclitaxelPhase 2
44
REOLYSIN® + Carboplatin + PaclitaxelPhase 2
44